Please sign in to follow a disease.
Prostatic neoplasms
Clinical trials for Prostatic neoplasms explained in plain language.
Never miss a new study
Get alerted when new Prostatic neoplasms trials appear
Sign up with your email to follow new studies for Prostatic neoplasms, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to outsmart resistant prostate cancer
Disease control Not yet recruitingResearchers are testing a new oral drug called JNJ-101556143 in people with metastatic prostate cancer that has stopped responding to hormone therapy. The trial aims to see if the drug can shrink tumors or make them disappear. About 100 participants will receive the drug, and doc…
Matched conditions: PROSTATIC NEOPLASMS
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 21, 2026 15:00 UTC
-
Radiation boost may extend Drug-Free time in prostate cancer recurrence
Disease control Not yet recruitingThis trial tests whether adding targeted radiation to standard hormone therapy can help men with recurring prostate cancer stay off cancer drugs longer. Men with a rising PSA and 1 to 5 metastases will receive either hormone therapy alone or hormone therapy plus radiation to the …
Matched conditions: PROSTATIC NEOPLASMS
Phase 3 • Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for hard-to-treat cancers? experimental combo enters phase 2 trial
Disease control Not yet recruitingThis study tests a new drug (GV20-0251) combined with an immunotherapy (anti-PD-1) in people with advanced solid tumors that have not responded to or cannot tolerate standard treatments. About 227 adults with various cancers, including lung, breast, and colorectal, will participa…
Matched conditions: PROSTATIC NEOPLASMS
Phase 2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New PET tracer targets ACP3 to spot prostate cancer
Diagnosis Not yet recruitingResearchers are testing a new PET imaging agent called [68Ga]Ga-OncoACP3 that targets a protein called ACP3, which is found in prostate cancer cells. The study enrolls 50 men with suspected or confirmed high-risk prostate cancer, or suspected recurrence after treatment. Each part…
Matched conditions: PROSTATIC NEOPLASMS
Phase 2 • Sponsor: Yong He • Aim: Diagnosis
Last updated Sep 21, 2026 15:00 UTC
-
Can a simple WhatsApp message save lives? chile tests new screening nudge
Knowledge-focused Not yet recruitingThis study will send different types of WhatsApp messages to 235,000 people in Chile who are due for cancer or chronic disease screenings. Researchers want to see if the way a message is worded (basic, risk-focused, or peace-of-mind) and whether it mentions one test or both tests…
Matched conditions: PROSTATIC NEOPLASMS
Sponsor: University of Chile • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC